News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
691,569 Results
Type
Article (39359)
Company Profile (247)
Press Release (651963)
Section
Business (204015)
Career Advice (2004)
Deals (35403)
Drug Delivery (90)
Drug Development (80943)
Employer Resources (169)
FDA (16125)
Job Trends (14826)
News (344860)
Policy (32472)
Tag
Academia (2531)
Alliances (49308)
Alzheimer's disease (1302)
Approvals (16097)
Artificial intelligence (191)
Bankruptcy (355)
Best Places to Work (11634)
Biotechnology (175)
Breast cancer (218)
Cancer (1631)
Cardiovascular disease (124)
Career advice (1670)
CAR-T (115)
Cell therapy (329)
Clinical research (65137)
Collaboration (629)
Compensation (351)
COVID-19 (2559)
C-suite (149)
Data (1539)
Diabetes (203)
Diagnostics (6252)
Earnings (85222)
Employer resources (146)
Events (110684)
Executive appointments (541)
FDA (16969)
Funding (569)
Gene therapy (227)
GLP-1 (640)
Government (4354)
Healthcare (18754)
Infectious disease (2664)
Inflammatory bowel disease (117)
Interviews (309)
IPO (16441)
Job creations (3630)
Job search strategy (1421)
Layoffs (432)
Legal (7882)
Lung cancer (245)
Manufacturing (227)
Medical device (13249)
Medtech (13254)
Mergers & acquisitions (19305)
Metabolic disorders (530)
Neuroscience (1691)
NextGen: Class of 2025 (6509)
Non-profit (4477)
Northern California (1979)
Obesity (301)
Opinion (190)
Patents (143)
People (56768)
Phase I (20280)
Phase II (28698)
Phase III (21370)
Pipeline (658)
Postmarket research (2562)
Preclinical (8568)
Radiopharmaceuticals (241)
Rare diseases (307)
Real estate (5895)
Regulatory (21850)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1714)
Startups (3570)
United States (17739)
Vaccines (602)
Weight loss (204)
Date
Today (105)
Last 7 days (629)
Last 30 days (2487)
Last 365 days (34700)
2025 (3391)
2024 (35222)
2023 (40080)
2022 (51180)
2021 (55721)
2020 (54087)
2019 (46543)
2018 (35023)
2017 (32116)
2016 (31493)
2015 (37558)
2014 (31320)
2013 (26345)
2012 (28571)
2011 (29264)
2010 (27328)
Location
Africa (716)
Arizona (208)
Asia (37467)
Australia (6126)
California (4539)
Canada (1644)
China (381)
Colorado (207)
Connecticut (214)
Europe (80292)
Florida (660)
Georgia (159)
Illinois (448)
Indiana (252)
Maryland (715)
Massachusetts (3488)
Michigan (194)
Minnesota (327)
New Jersey (1291)
New York (1302)
North Carolina (812)
Northern California (1979)
Ohio (166)
Pennsylvania (1060)
South America (1094)
Southern California (1714)
Texas (665)
Utah (137)
Washington State (454)
691,569 Results for "92bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Leveragen and 92Bio Forge Strategic Alliance to Advance Therapeutics Using Novel Single Domain Antibody Platform
Leveragen, Inc. announced today that it has entered into a multi-target commercial license agreement with 92Bio, Inc., a biotech firm focused on the development of therapeutic antibodies.
May 28, 2024
·
3 min read
Press Releases
Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company
January 15, 2025
·
5 min read
Genetown
Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders
Triveni Bio Inc. announced a $92 million series A financing co-led by Atlas Venture and Cormorant Asset Management, with participation from OrbiMed, the private equity business of Viking Global Investors, Invus, Polaris Partners, Alexandria Venture Investments, and other investors.
October 26, 2023
·
3 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) and HOPE Therapeutics™, Inc. to Present at the Oppenheimer 35th Annual Healthcare Conference on February 12, 2025
February 7, 2025
·
4 min read
Press Releases
Medera, Inc. to Participate in Two Upcoming Investor Conferences
February 7, 2025
·
12 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 3, 2025
·
1 min read
1 of 69,157
Next
